{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T06:29:11Z","timestamp":1793860151766,"version":"4.6.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","award":["HCP-41"],"award-info":[{"award-number":["HCP-41"]}],"id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","award":["HCP-41"],"award-info":[{"award-number":["HCP-41"]}],"id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012323","name":"CSIR - Indian Institute of Chemical Biology","doi-asserted-by":"publisher","award":["OLP118"],"award-info":[{"award-number":["OLP118"]}],"id":[{"id":"10.13039\/501100012323","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"DOI":"10.1007\/s11030-026-11724-x","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T13:42:37Z","timestamp":1790170957000},"page":"11177-11202","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Discovery of a new SARS-CoV-2 Mpro inhibitor from a natural product and natural product-like compound database using in silico and in vitro studies"],"prefix":"10.1007","volume":"30","author":[{"given":"Sudesna","family":"Das","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uttam","family":"Pal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2482-8534","authenticated-orcid":false,"given":"Yasmin","family":"Begum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akshay","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nittu","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishan Gopal","family":"Thakur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umesh Prasad","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,23]]},"reference":[{"key":"11724_CR1","doi-asserted-by":"publisher","first-page":"6595","DOI":"10.1021\/acs.jmedchem.5b01461","volume":"59","author":"T Pillaiyar","year":"2016","unstructured":"Pillaiyar T, Manickam M, Namasivayam V et al (2016) An overview of severe acute respiratory syndrome-coronavirus (SARS-CoV) 3CL protease inhibitors: peptidomimetics and small molecule chemotherapy. J Med Chem 59:6595\u20136628. https:\/\/doi.org\/10.1021\/acs.jmedchem.5b01461","journal-title":"J Med Chem"},{"key":"11724_CR2","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","volume":"395","author":"R Lu","year":"2020","unstructured":"Lu R, Zhao X, Li J et al (2020) Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 395:565\u2013574. https:\/\/doi.org\/10.1016\/S0140-6736(20)30251-8","journal-title":"Lancet"},{"key":"11724_CR3","unstructured":"Padda IS, Parmar M (2025) COVID (SARS-CoV-2) vaccine. StatPearls Publishing https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK567793\/"},{"key":"11724_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/SCITRANSLMED.ABB5883","volume":"12","author":"TP Sheahan","year":"2020","unstructured":"Sheahan TP, Sims AC, Zhou S et al (2020) An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice. Sci Transl Med 12:1\u201320. https:\/\/doi.org\/10.1126\/SCITRANSLMED.ABB5883","journal-title":"Sci Transl Med"},{"key":"11724_CR5","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1056\/nejmoa2001282","volume":"382","author":"B Cao","year":"2020","unstructured":"Cao B, Wang Y, Wen D et al (2020) A trial of lopinavir\u2013ritonavir in adults hospitalized with severe Covid-19. N Engl J Med 382:1787\u20131799. https:\/\/doi.org\/10.1056\/nejmoa2001282","journal-title":"N Engl J Med"},{"key":"11724_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/AAC.00399-20","volume":"64","author":"MA Martinez","year":"2020","unstructured":"Martinez MA (2020) Compounds with therapeutic potential against novel respiratory 2019 coronavirus. Antimicrob Agents Chemother 64:1\u20137. https:\/\/doi.org\/10.1128\/AAC.00399-20","journal-title":"Antimicrob Agents Chemother"},{"key":"11724_CR7","doi-asserted-by":"publisher","first-page":"486","DOI":"10.3390\/v12050486","volume":"12","author":"S Kumar","year":"2020","unstructured":"Kumar S, Zhi K, Mukherji A, Gerth K (2020) Repurposing antiviral protease inhibitors using extracellular vesicles for potential therapy of COVID-19. Viruses 12:486. https:\/\/doi.org\/10.3390\/v12050486","journal-title":"Viruses"},{"key":"11724_CR8","doi-asserted-by":"publisher","first-page":"797","DOI":"10.3390\/biom14070797","volume":"14","author":"A Zag\u00f3rska","year":"2024","unstructured":"Zag\u00f3rska A, Czopek A, Fryc M, Jo\u0144czyk J (2024) Inhibitors of SARS-CoV-2 main protease (Mpro) as anti-coronavirus agents. Biomolecules 14:797. https:\/\/doi.org\/10.3390\/biom14070797","journal-title":"Biomolecules"},{"key":"11724_CR9","doi-asserted-by":"publisher","first-page":"259","DOI":"10.3390\/ijms23010259","volume":"23","author":"G Macip","year":"2021","unstructured":"Macip G, Garcia-Segura P, Mestres-Truyol J et al (2021) A review of the current landscape of SARS-CoV-2 main protease inhibitors: Have we hit the bullseye yet? Int J Mol Sci 23:259. https:\/\/doi.org\/10.3390\/ijms23010259","journal-title":"Int J Mol Sci"},{"key":"11724_CR10","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/s41586-020-2223-y","volume":"582","author":"Z Jin","year":"2020","unstructured":"Jin Z, Du X, Xu Y et al (2020) Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors. Nature 582:289\u2013293. https:\/\/doi.org\/10.1038\/s41586-020-2223-y","journal-title":"Nature"},{"key":"11724_CR11","doi-asserted-by":"publisher","first-page":"12500","DOI":"10.1021\/acs.jmedchem.2c01005","volume":"65","author":"G La Monica","year":"2022","unstructured":"La Monica G, Bono A, Lauria A, Martorana A (2022) Targeting SARS-CoV-2 main protease for treatment of COVID-19: covalent inhibitors structure\u2013activity relationship insights and evolution perspectives. J Med Chem 65:12500\u201312534. https:\/\/doi.org\/10.1021\/acs.jmedchem.2c01005","journal-title":"J Med Chem"},{"key":"11724_CR12","doi-asserted-by":"publisher","DOI":"10.1080\/14756366.2025.2460045","author":"N Atatreh","year":"2025","unstructured":"Atatreh N, Mahgoub RE, Ghattas MA (2025) Exploring covalent inhibitors of SARS-CoV-2 main protease: from peptidomimetics to novel scaffolds. J Enzyme Inhib Med Chem. https:\/\/doi.org\/10.1080\/14756366.2025.2460045","journal-title":"J Enzyme Inhib Med Chem"},{"key":"11724_CR13","doi-asserted-by":"publisher","first-page":"44","DOI":"10.2174\/0127724344379865250709163918","volume":"21","author":"DK Lokwani","year":"2026","unstructured":"Lokwani DK, Chavan SR, Jain SP et al (2026) Computational investigation of natural substances as SARS-CoV-2 main protease inhibitors: a virtual screening method. Recent Adv Anti- Infect Drug Discov 21:44\u201358. https:\/\/doi.org\/10.2174\/0127724344379865250709163918","journal-title":"Recent Adv Anti Infect Drug Discov"},{"key":"11724_CR14","doi-asserted-by":"publisher","first-page":"8377","DOI":"10.3390\/ijms24098377","volume":"24","author":"A Bono","year":"2023","unstructured":"Bono A, Lauria A, La Monica G et al (2023) In silico design of new dual inhibitors of SARS-CoV-2 MPRO through ligand- and structure-based methods. Int J Mol Sci 24:8377. https:\/\/doi.org\/10.3390\/ijms24098377","journal-title":"Int J Mol Sci"},{"key":"11724_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/s11030-025-11315-2","author":"S Das","year":"2025","unstructured":"Das S, Sunnapu P, Rafi M et al (2025) 9-fluorenone-based synthetic sulfonamide compounds as dual inhibitors of SARS-CoV-2 main-protease and papain-like protease. Mol Divers. https:\/\/doi.org\/10.1007\/s11030-025-11315-2","journal-title":"Mol Divers"},{"key":"11724_CR16","doi-asserted-by":"publisher","first-page":"109100","DOI":"10.1016\/j.jmgm.2025.109100","volume":"140","author":"A Bono","year":"2025","unstructured":"Bono A, La Monica G, Alamia F et al (2025) Combinatorial chemistry-driven In silico design and computational evaluation of covalent peptidomimetic SARS-CoV-2 main protease inhibitors via structure-based virtual screening and multivariate analysis. J Mol Graph Model 140:109100. https:\/\/doi.org\/10.1016\/j.jmgm.2025.109100","journal-title":"J Mol Graph Model"},{"key":"11724_CR17","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1080\/14756366.2021.1873977","volume":"36","author":"H Liu","year":"2021","unstructured":"Liu H, Ye F, Sun Q et al (2021) Scutellaria baicalensis extract and baicalein inhibit replication of SARS-CoV-2 and its 3\u00a0C-like protease in vitro. J Enzyme Inhib Med Chem 36:497\u2013503. https:\/\/doi.org\/10.1080\/14756366.2021.1873977","journal-title":"J Enzyme Inhib Med Chem"},{"key":"11724_CR18","doi-asserted-by":"publisher","first-page":"7048","DOI":"10.3390\/ijms22137048","volume":"22","author":"F Mangiavacchi","year":"2021","unstructured":"Mangiavacchi F, Botwina P, Menichetti E et al (2021) Seleno-functionalization of quercetin improves the non-covalent inhibition of Mpro and its antiviral activity in cells against SARS-CoV-2. Int J Mol Sci 22:7048. https:\/\/doi.org\/10.3390\/ijms22137048","journal-title":"Int J Mol Sci"},{"key":"11724_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/biomedicines9040375","volume":"9","author":"B Rizzuti","year":"2021","unstructured":"Rizzuti B, Grande F, Conforti F et al (2021) Rutin is a low micromolar inhibitor of sars-cov-2 main protease 3clpro: implications for drug design of quercetin analogs. Biomedicines 9:1\u201320. https:\/\/doi.org\/10.3390\/biomedicines9040375","journal-title":"Biomedicines"},{"key":"11724_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/3697498","volume":"2022","author":"H Onyango","year":"2022","unstructured":"Onyango H, Odhiambo P, Angwenyi D, Okoth P (2022) In silico identification of new anti-SARS-CoV-2 main protease (Mpro) molecules with pharmacokinetic properties from natural sources using molecular dynamics (MD) simulations and hierarchical virtual screening. J Trop Med 2022:1\u201322. https:\/\/doi.org\/10.1155\/2022\/3697498","journal-title":"J Trop Med"},{"key":"11724_CR21","doi-asserted-by":"publisher","first-page":"6810","DOI":"10.1080\/07391102.2020.1806930","volume":"39","author":"K Kapusta","year":"2021","unstructured":"Kapusta K, Kar S, Collins JT et al (2021) Protein reliability analysis and virtual screening of natural inhibitors for SARS-CoV-2 main protease (Mpro) through docking, molecular mechanic & dynamic, and ADMET profiling. J Biomol Struct Dyn 39:6810\u20136827. https:\/\/doi.org\/10.1080\/07391102.2020.1806930","journal-title":"J Biomol Struct Dyn"},{"key":"11724_CR22","doi-asserted-by":"publisher","first-page":"103845","DOI":"10.1016\/j.sjbs.2023.103845","volume":"30","author":"NA Ahamed","year":"2023","unstructured":"Ahamed NA, Arif IA (2023) Finding potential inhibitors for main protease (Mpro) of SARS-CoV-2 through virtual screening and MD simulation studies. Saudi J Biol Sci 30:103845. https:\/\/doi.org\/10.1016\/j.sjbs.2023.103845","journal-title":"Saudi J Biol Sci"},{"key":"11724_CR23","doi-asserted-by":"publisher","first-page":"519","DOI":"10.3390\/biology12040519","volume":"12","author":"D Ang","year":"2023","unstructured":"Ang D, Kendall R, Atamian H (2023) Virtual and in vitro screening of natural products identifies indole and benzene derivatives as inhibitors of SARS-CoV-2 main protease (Mpro). Biology (Basel) 12:519. https:\/\/doi.org\/10.3390\/biology12040519","journal-title":"Biology (Basel)"},{"key":"11724_CR24","doi-asserted-by":"publisher","first-page":"3627","DOI":"10.1080\/07391102.2020.1769733","volume":"39","author":"MT Khan","year":"2021","unstructured":"Khan MT, Ali A, Wang Q et al (2021) Marine natural compounds as potents inhibitors against the main protease of SARS-CoV-2\u2014a molecular dynamic study. J Biomol Struct Dyn 39:3627\u20133637. https:\/\/doi.org\/10.1080\/07391102.2020.1769733","journal-title":"J Biomol Struct Dyn"},{"key":"11724_CR25","doi-asserted-by":"publisher","first-page":"13168","DOI":"10.1080\/07391102.2023.2175377","volume":"41","author":"VR Patil","year":"2023","unstructured":"Patil VR, Dhote AM, Patil R et al (2023) Identification of structural scaffold from interbioscreen (IBS) database to inhibit 3CLpro, PLpro, and RdRp of SARS-CoV-2 using molecular docking and dynamic simulation studies. J Biomol Struct Dyn 41:13168\u201313179. https:\/\/doi.org\/10.1080\/07391102.2023.2175377","journal-title":"J Biomol Struct Dyn"},{"key":"11724_CR26","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1021\/acs.jcim.2c01309","volume":"63","author":"N Khamto","year":"2023","unstructured":"Khamto N, Utama K, Tateing S et al (2023) Discovery of natural bisbenzylisoquinoline analogs from the library of Thai traditional plants as SARS-CoV-2 3CLPro inhibitors: in silico molecular docking, molecular dynamics, and in vitro enzymatic activity. J Chem Inf Model 63:2104\u20132121. https:\/\/doi.org\/10.1021\/acs.jcim.2c01309","journal-title":"J Chem Inf Model"},{"key":"11724_CR27","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1016\/j.str.2017.10.009","volume":"25","author":"S Gore","year":"2017","unstructured":"Gore S, Sanz Garc\u00eda E, Hendrickx PMS et al (2017) Validation of structures in the protein data bank. Structure 25:1916\u20131927. https:\/\/doi.org\/10.1016\/j.str.2017.10.009","journal-title":"Structure"},{"key":"11724_CR28","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1107\/S2059798318003303","volume":"74","author":"OS Smart","year":"2018","unstructured":"Smart OS, Horsk\u00fd V, Gore S et al (2018) Worldwide protein data bank validation information: usage and trends. Acta Crystallogr Sect D Struct Biol 74:237\u2013244. https:\/\/doi.org\/10.1107\/S2059798318003303","journal-title":"Acta Crystallogr Sect D Struct Biol"},{"key":"11724_CR29","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott O, Olson AJ (2010) AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31:455\u2013461. https:\/\/doi.org\/10.1002\/jcc.21334","journal-title":"J Comput Chem"},{"key":"11724_CR30","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1021\/acs.langmuir.9b03506","volume":"36","author":"B Chakraborty","year":"2020","unstructured":"Chakraborty B, Sengupta C, Pal U, Basu S (2020) Probing the hydrogen bond involving acridone trapped in a hydrophobic biological nanocavity: integrated spectroscopic and docking analyses. Langmuir 36:1241\u20131251. https:\/\/doi.org\/10.1021\/acs.langmuir.9b03506","journal-title":"Langmuir"},{"key":"11724_CR31","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"GM Morris","year":"2009","unstructured":"Morris GM, Huey R, Lindstrom W et al (2009) AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem 30:2785\u20132791. https:\/\/doi.org\/10.1002\/jcc.21256","journal-title":"J Comput Chem"},{"key":"11724_CR32","doi-asserted-by":"publisher","first-page":"3202","DOI":"10.1038\/s41467-020-16954-7","volume":"11","author":"DW Kneller","year":"2020","unstructured":"Kneller DW, Phillips G, O\u2019Neill HM et al (2020) Structural plasticity of SARS-CoV-2 3CL Mpro active site cavity revealed by room temperature X-ray crystallography. Nat Commun 11:3202. https:\/\/doi.org\/10.1038\/s41467-020-16954-7","journal-title":"Nat Commun"},{"key":"11724_CR33","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1758-2946-4-17","volume":"4","author":"MD Hanwell","year":"2012","unstructured":"Hanwell MD, Curtis DE, Lonie DC et al (2012) Avogadro: an advanced semantic chemical editor, visualization, and analysis platform. J Cheminform 4:17. https:\/\/doi.org\/10.1186\/1758-2946-4-17","journal-title":"J Cheminform"},{"key":"11724_CR34","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott O, Olson AJ (2010) AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31:455\u2013461. https:\/\/doi.org\/10.1002\/jcc.21334","journal-title":"J Comput Chem"},{"key":"11724_CR35","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","volume":"61","author":"J Eberhardt","year":"2021","unstructured":"Eberhardt J, Santos-Martins D, Tillack AF, Forli S (2021) AutoDock Vina 1.2.0: new docking methods, expanded force field, and python bindings. J Chem Inf Model 61:3891\u20133898. https:\/\/doi.org\/10.1021\/acs.jcim.1c00203","journal-title":"J Chem Inf Model"},{"key":"11724_CR36","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1002\/JCC.20289","volume":"26","author":"JC Phillips","year":"2005","unstructured":"Phillips JC, Braun R, Wang W et al (2005) Scalable molecular dynamics with NAMD. J Comput Chem 26:1781\u20131802. https:\/\/doi.org\/10.1002\/JCC.20289","journal-title":"J Comput Chem"},{"key":"11724_CR37","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","volume":"14","author":"W Humphrey","year":"1996","unstructured":"Humphrey W, Dalke A, Schulten K (1996) VMD: visual molecular dynamics. J Mol Graph 14:33\u201338. https:\/\/doi.org\/10.1016\/0263-7855(96)00018-5","journal-title":"J Mol Graph"},{"key":"11724_CR38","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1021\/acs.jctc.5b00935","volume":"12","author":"J Lee","year":"2016","unstructured":"Lee J, Cheng X, Swails JM et al (2016) CHARMM-GUI input generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM\/OpenMM simulations using the CHARMM36 additive force field. J Chem Theory Comput 12:405\u2013413. https:\/\/doi.org\/10.1021\/acs.jctc.5b00935","journal-title":"J Chem Theory Comput"},{"key":"11724_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/bib\/bbaa161","volume":"22","author":"Q Bai","year":"2021","unstructured":"Bai Q, Tan S, Xu T et al (2021) MolAICal: a soft tool for 3D drug design of protein targets by artificial intelligence and classical algorithm. Brief Bioinform 22:1\u201312. https:\/\/doi.org\/10.1093\/bib\/bbaa161","journal-title":"Brief Bioinform"},{"key":"11724_CR40","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/S0022-2836(03)00610-7","volume":"330","author":"H Gohlke","year":"2003","unstructured":"Gohlke H, Kiel C, Case DA (2003) Insights into protein-protein binding by binding free energy calculation and free energy decomposition for the Ras-Raf and Ras-RalGDS complexes. J Mol Biol 330:891\u2013913. https:\/\/doi.org\/10.1016\/S0022-2836(03)00610-7","journal-title":"J Mol Biol"},{"key":"11724_CR41","doi-asserted-by":"publisher","first-page":"2791","DOI":"10.1002\/jcc.25072","volume":"38","author":"D DasGupta","year":"2017","unstructured":"DasGupta D, Mandalaparthy V, Jayaram B (2017) A component analysis of the free energies of folding of 35 proteins: a consensus view on the thermodynamics of folding at the molecular level. J Comput Chem 38:2791\u20132801. https:\/\/doi.org\/10.1002\/jcc.25072","journal-title":"J Comput Chem"},{"key":"11724_CR42","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina A, Michielin O, Zoete V (2017) SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 7:42717. https:\/\/doi.org\/10.1038\/srep42717","journal-title":"Sci Rep"},{"key":"11724_CR43","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","volume":"58","author":"DEV Pires","year":"2015","unstructured":"Pires DEV, Blundell TL, Ascher DB (2015) pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J Med Chem 58:4066\u20134072. https:\/\/doi.org\/10.1021\/acs.jmedchem.5b00104","journal-title":"J Med Chem"},{"key":"11724_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-021-22362-2","volume":"12","author":"S Iketani","year":"2021","unstructured":"Iketani S, Forouhar F, Liu H et al (2021) Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors. Nat Commun 12:1\u201324. https:\/\/doi.org\/10.1038\/s41467-021-22362-2","journal-title":"Nat Commun"},{"key":"11724_CR45","doi-asserted-by":"publisher","first-page":"125444","DOI":"10.1016\/j.ijbiomac.2023.125444","volume":"245","author":"S Mani","year":"2023","unstructured":"Mani S, Kaur A, Jakhar K et al (2023) Targeting DPP4-RBD interactions by sitagliptin and linagliptin delivers a potential host-directed therapy against pan-SARS-CoV-2 infections. Int J Biol Macromol 245:125444. https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.125444","journal-title":"Int J Biol Macromol"},{"key":"11724_CR46","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1177\/1087057114556253","volume":"20","author":"R Mudhasani","year":"2015","unstructured":"Mudhasani R, Kota KP, Retterer C et al (2015) High-content image\u2013based screening of a signal transduction pathway inhibitor small-molecule library against highly pathogenic RNA viruses. SLAS Discov 20:141\u2013152. https:\/\/doi.org\/10.1177\/1087057114556253","journal-title":"SLAS Discov"},{"key":"11724_CR47","doi-asserted-by":"publisher","first-page":"e3095","DOI":"10.1371\/journal.pntd.0003095","volume":"8","author":"R Mudhasani","year":"2014","unstructured":"Mudhasani R, Kota KP, Retterer C et al (2014) High content image-based screening of a protease inhibitor library reveals compounds broadly active against rift valley fever virus and other highly pathogenic RNA viruses. PLoS Negl Trop Dis 8:e3095. https:\/\/doi.org\/10.1371\/journal.pntd.0003095","journal-title":"PLoS Negl Trop Dis"},{"key":"11724_CR48","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.3390\/v15122416","volume":"15","author":"GE Sotorilli","year":"2023","unstructured":"Sotorilli GE, Gravina HD, de Carvalho AC et al (2023) Phenotypical screening of an MMV open box library and identification of compounds with antiviral activity against St. Louis Encephalitis virus. Viruses 15:2416. https:\/\/doi.org\/10.3390\/v15122416","journal-title":"Viruses"},{"key":"11724_CR49","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1186\/s12985-024-02607-4","volume":"21","author":"S Gevorgyan","year":"2024","unstructured":"Gevorgyan S, Khachatryan H, Shavina A et al (2024) Targeting SARS-CoV-2 main protease: a comprehensive approach using advanced virtual screening, molecular dynamics, and in vitro validation. Virol J 21:330. https:\/\/doi.org\/10.1186\/s12985-024-02607-4","journal-title":"Virol J"},{"key":"11724_CR50","doi-asserted-by":"publisher","first-page":"110391","DOI":"10.1016\/j.abb.2025.110391","volume":"768","author":"P Zardi","year":"2025","unstructured":"Zardi P, Righino B, Pirolli D et al (2025) Design and synthesis of pyridopyrimidines targeting NEK6 kinase. Arch Biochem Biophys 768:110391. https:\/\/doi.org\/10.1016\/j.abb.2025.110391","journal-title":"Arch Biochem Biophys"},{"key":"11724_CR51","doi-asserted-by":"publisher","first-page":"8440","DOI":"10.1073\/pnas.0803096105","volume":"105","author":"AY Kots","year":"2008","unstructured":"Kots AY, Choi B-K, Estrella-Jimenez ME et al (2008) Pyridopyrimidine derivatives as inhibitors of cyclic nucleotide synthesis: application for treatment of diarrhea. Proc Natl Acad Sci 105:8440\u20138445. https:\/\/doi.org\/10.1073\/pnas.0803096105","journal-title":"Proc Natl Acad Sci"},{"key":"11724_CR52","doi-asserted-by":"publisher","unstructured":"Griffen EJ, Fearon D, McGovern BL et al (2025) Open-science discovery of DNDI-6510, a compound that addresses genotoxic and metabolic liabilities of the COVID Moonshot SARS-CoV-2 Mpro lead inhibitor. bioRxiv : the preprint server for biology 2025.06.16.660018. https:\/\/doi.org\/10.1101\/2025.06.16.660018","DOI":"10.1101\/2025.06.16.660018"},{"key":"11724_CR53","doi-asserted-by":"publisher","first-page":"3983","DOI":"10.2174\/0115701808330125240812104856","volume":"21","author":"J Wu","year":"2024","unstructured":"Wu J, Li P, Mu Y et al (2024) Structural optimization of quinazolin-4-one derivatives as novel SARS-CoV-2 Mpro inhibitors by molecular simulation. Lett Drug Des Discov 21:3983\u20133997. https:\/\/doi.org\/10.2174\/0115701808330125240812104856","journal-title":"Lett Drug Des Discov"},{"key":"11724_CR54","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s11259-025-10742-8","volume":"49","author":"I Gul","year":"2025","unstructured":"Gul I, Isham IM, Najimudeen SM et al (2025) An integrated in silico and ex vivo study identifies quinazolinedione L134716 as a potential inhibitor of infectious bronchitis virus. Vet Res Commun 49:175. https:\/\/doi.org\/10.1007\/s11259-025-10742-8","journal-title":"Vet Res Commun"},{"key":"11724_CR55","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1021\/jm901137j","volume":"53","author":"JB Baell","year":"2010","unstructured":"Baell JB, Holloway GA (2010) New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. J Med Chem 53:2719\u20132740. https:\/\/doi.org\/10.1021\/jm901137j","journal-title":"J Med Chem"},{"key":"11724_CR56","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1021\/acschembio.7b00903","volume":"13","author":"JB Baell","year":"2018","unstructured":"Baell JB, Nissink JWM (2018) Seven year itch: pan-assay interference compounds (PAINS) in 2017\u2014utility and limitations. ACS Chem Biol 13:36\u201344. https:\/\/doi.org\/10.1021\/acschembio.7b00903","journal-title":"ACS Chem Biol"},{"key":"11724_CR57","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1021\/acs.jcim.6b00465","volume":"57","author":"SJ Capuzzi","year":"2017","unstructured":"Capuzzi SJ, Muratov EN, Tropsha A (2017) Phantom PAINS: problems with the utility of alerts for pan- assay interference compounds. J Chem Inf Model 57:417\u2013427. https:\/\/doi.org\/10.1021\/acs.jcim.6b00465","journal-title":"J Chem Inf Model"},{"key":"11724_CR58","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.foodchem.2009.10.047","volume":"120","author":"KS Parvathy","year":"2010","unstructured":"Parvathy KS, Negi PS, Srinivas P (2010) Curcumin-amino acid conjugates: synthesis, antioxidant and antimutagenic attributes. Food Chem 120:523\u2013530. https:\/\/doi.org\/10.1016\/j.foodchem.2009.10.047","journal-title":"Food Chem"},{"key":"11724_CR59","doi-asserted-by":"publisher","first-page":"5117","DOI":"10.1039\/d4ra08496a","volume":"15","author":"H Ye","year":"2025","unstructured":"Ye H, Cai J, Shen Z et al (2025) Synergistic polyphenol-amino acid nanoparticles: a new strategy for reactive oxygen species management. RSC Adv 15:5117\u20135123. https:\/\/doi.org\/10.1039\/d4ra08496a","journal-title":"RSC Adv"},{"key":"11724_CR60","doi-asserted-by":"publisher","first-page":"2991","DOI":"10.1021\/acschemneuro.2c00502","volume":"13","author":"A Stasiulewicz","year":"2022","unstructured":"Stasiulewicz A, Lesniak A, Setny P et al (2022) Identification of CB1 ligands among drugs, phytochemicals and natural-like compounds: virtual screening and in vitro verification. ACS Chem Neurosci 13:2991\u20133007. https:\/\/doi.org\/10.1021\/acschemneuro.2c00502","journal-title":"ACS Chem Neurosci"},{"key":"11724_CR61","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1186\/s13065-024-01317-w","volume":"18","author":"A Mili","year":"2024","unstructured":"Mili A, Birangal S, Giridhar J et al (2024) Identification of phytomolecules as isoform and mutation specific PI3K-\u03b1 inhibitor for protection against breast cancer using e-pharmacophore modeling and molecular dynamics simulations. BMC Chem 18:241. https:\/\/doi.org\/10.1186\/s13065-024-01317-w","journal-title":"BMC Chem"},{"key":"11724_CR62","doi-asserted-by":"publisher","first-page":"5496","DOI":"10.1111\/febs.16947","volume":"290","author":"A Trivedi","year":"2023","unstructured":"Trivedi A, Kardam V, Inampudi KK et al (2023) Identification of a novel inhibitor of SARS-CoV-2 main protease: an in silico, biochemical, and cell-based approach. FEBS J 290:5496\u20135513. https:\/\/doi.org\/10.1111\/febs.16947","journal-title":"FEBS J"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-026-11724-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-026-11724-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-026-11724-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T06:04:35Z","timestamp":1793858675000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-026-11724-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,23]]},"references-count":62,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["11724"],"URL":"https:\/\/doi.org\/10.1007\/s11030-026-11724-x","relation":{},"ISSN":["1573-501X"],"issn-type":[{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,23]]},"assertion":[{"value":"5 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}